Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis
Fraenkel L, Nowell WB, Michel G, Wiedmeyer C. Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis. Annals Of The Rheumatic Diseases 2017, 77: 678. PMID: 29247126, PMCID: PMC5898982, DOI: 10.1136/annrheumdis-2017-212407.Peer-Reviewed Original ResearchConceptsBothersome side effectsRare side effectRheumatoid arthritisSide effectsSerious infectionsOnset of actionJanus kinase inhibitorPreferences of patientsMethotrexate monotherapyTriple therapyParenteral medicationsPoint of careTreatment preferencesGroup 2Patient valuesPatientsGroup 4Target strategyGroup 5Kinase inhibitorsConjoint analysis surveyLatent class analysisLarge groupArthritisMedicationsAB0370 Development of patient preference phenotypes for rheumatoid arthritis
Nowell W, Wiedmeyer C, Herath G, Michel G, Fraenkel L. AB0370 Development of patient preference phenotypes for rheumatoid arthritis. Annals Of The Rheumatic Diseases 2017, 76: 1177. DOI: 10.1136/annrheumdis-2017-eular.5024.Peer-Reviewed Original ResearchRheumatoid arthritisPatient preferencesRA patients’ preferencesPatient-physician dyadPreference-sensitive decisionsImportant treatment decisionsOnline patient communityMethotrexate monotherapyRA medicationsTriple therapyClinical characteristicsMean ageTreatment optionsTreatment decisionsPatient feedbackPatient communityPatientsConjoint analysis surveyImportant quality measureLatent class analysisCareArthritisPreference phenotypesDistinct phenotypesPhenotype